Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 3 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v10i2: pp. 37-55 Michael O’Hara, Graham Mitenko Misc-Not classified 2000
v8i2: pp. 33-48 Graham Mitenko; Henry Okleshen Business Valuation and Lost Profits 1998
No products in the cart.